BRUSKY SEAN P. enters PRELUDE THERAPEUTICS INC with 100K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/19/2026ACC: 0000929638-26-001070
Officer· Chief Business Officer
Since Mar 2026
100K
Baseline shares
100% direct
100K
Direct ownership
1 position
750K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned100K
Total
100K direct100K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 100K | Direct |
| Total | 100K | 100K direct |
Derivative Holdings3
Employee Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
300K
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Employee Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
275K
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Employee Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
175K
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Total
Underlying
750K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock | 0 | — | — | 300K | N/A |
| Employee Stock Option (Right to Buy) Direct | Common Stock | 0 | — | — | 275K | N/A |
| Employee Stock Option (Right to Buy) Direct | Common Stock | 0 | — | — | 175K | N/A |
| Total | 750K | 0.00 | ||||